Jan 6, 2014


1. India is considering a proposal to amend Rule 122(E) of the Drugs and Cosmetics Act to include products with new drug delivery systems (such as time-release, modified release, etc.) under the "new drug" category. From a practical standpoint what this means is that drug makers who launch differentiated products using such new drug delivery […]
back to top